{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:30:01Z","timestamp":1793788201451,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jhlto.2026.100677","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T06:03:14Z","timestamp":1788156194000},"page":"100677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Percutaneous coronary intervention in cardiac allograft vasculopathy: From lesion selection to longitudinal graft management"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9249-4103","authenticated-orcid":false,"given":"Ajay","family":"Dharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6405-9398","authenticated-orcid":false,"given":"Muhammed Faraz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1863-092X","authenticated-orcid":false,"given":"Nalin","family":"Dayawansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2026.100677_bib1","first-page":"2624","article-title":"Cardiac allograft vasculopathy: current review and future research directions","volume":"117","author":"Pober","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jhlto.2026.100677_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.14797\/mdcvj.1580","article-title":"Cardiac allograft vasculopathy: a focus on advances in diagnosis and management","volume":"21","author":"Stomberski","year":"2025","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.jhlto.2026.100677_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/acs.2018.01.10","article-title":"Percutaneous coronary intervention versus coronary artery bypass grafting in heart transplant recipients with coronary allograft vasculopathy: a systematic review and meta-analysis of 1,520 patients","volume":"7","author":"Luc","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.jhlto.2026.100677_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5114\/aoms.2017.71847","article-title":"Coronary revascularization after heart transplant - the search for prognostic factors","volume":"16","author":"Guzik","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jhlto.2026.100677_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jamacardio.2020.0586","article-title":"Omission of heart transplant recipients from the appropriate use criteria for revascularization and the ramifications on heart transplant centers","volume":"5","author":"Xie","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jhlto.2026.100677_bib6","article-title":"Invasive coronary imaging assessment for cardiac allograft vasculopathy: state-of-the-art review","volume":"1","author":"Shahandeh","year":"2022","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jhlto.2026.100677_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.115.018741","article-title":"Invasive assessment of coronary physiology predicts late mortality after heart transplantation","volume":"133","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100677_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2026.100677_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd11030095","article-title":"Cardiac allograft vasculopathy: challenges and advances in invasive and non-invasive diagnostic modalities","volume":"11","author":"Kamel","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.jhlto.2026.100677_bib10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/TP.0000000000001322","article-title":"Donor-transmitted atherosclerosis associated with worsening cardiac allograft vasculopathy after heart transplantation: serial volumetric intravascular ultrasound analysis","volume":"101","author":"Watanabe","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2026.100677_bib11","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.healun.2023.07.006","article-title":"Early optical coherence tomography evaluation of donor-transmitted atherosclerosis and cardiac allograft vasculopathy: insights from a prospective, single-center study","volume":"42","author":"Takahashi","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2026.100677_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/TP.0b013e318273878c","article-title":"Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study","volume":"95","author":"Topilsky","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2026.100677_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11133731","article-title":"De novo complement-binding anti-HLA antibodies in heart transplanted patients is associated with severe cardiac allograft vasculopathy and poor long-term survival","volume":"11","author":"Baudry","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhlto.2026.100677_bib14","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1007\/s00330-025-12200-0","article-title":"Temporal changes in coronary artery calcium in heart transplantation patients","volume":"36","author":"Sharma","year":"2026","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhlto.2026.100677_bib15","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.transproceed.2023.09.009","article-title":"Elevated lipoprotein A levels and development of moderate or severe cardiac allograft vasculopathy in patients with heart transplants","volume":"55","author":"Gonzalez-Quijano","year":"2023","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhlto.2026.100677_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jacl.2024.12.011","article-title":"The association between lipoprotein(a) levels and the development of cardiac allograft vasculopathy","volume":"19","author":"Abbas","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jhlto.2026.100677_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2020.10.001","article-title":"3-Year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation","volume":"14","author":"Gao","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jhlto.2026.100677_bib18","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2014.01.071","article-title":"Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials","volume":"63","author":"Wever-Pinzon","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2026.100677_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017197","article-title":"Comprehensive non-invasive versus invasive approach to evaluate cardiac allograft vasculopathy in heart transplantation: The CCTA-HTx study","volume":"18","author":"Belmonte","year":"2025","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jhlto.2026.100677_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2967\/jnumed.124.268713","article-title":"PET\/CT with myocardial blood flow assessment is prognostic of cardiac allograft vasculopathy progression and clinical outcomes","volume":"66","author":"Prasad","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jhlto.2026.100677_bib21","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.healun.2016.05.012","article-title":"Dobutamine stress echocardiography is inadequate to detect early cardiac allograft vasculopathy","volume":"35","author":"Clerkin","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2026.100677_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-018-0515-2","article-title":"Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients","volume":"21","author":"Kazmirczak","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jhlto.2026.100677_bib23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4244\/EIJ-D-23-00194","article-title":"Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology","volume":"19","author":"Escaned","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jhlto.2026.100677_bib24","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1093\/eurheartj\/ehab568","article-title":"Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation","volume":"42","author":"Ahn","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhlto.2026.100677_bib25","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2021.10.009","article-title":"Microcirculatory resistance predicts allograft rejection and cardiac events after heart transplantation","volume":"78","author":"Ahn","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2026.100677_bib26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1161\/CIRCULATIONAHA.121.056158","article-title":"Coronary microcirculatory dysfunction and acute cellular rejection after heart transplantation","volume":"144","author":"Lee","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100677_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/CIRCULATIONAHA.116.025268","article-title":"Coronary endothelial dysfunction and the index of microcirculatory resistance as a marker of subsequent development of cardiac allograft vasculopathy","volume":"135","author":"Lee","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100677_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000524781","article-title":"Coronary artery revascularization in heart transplant patients: a systematic review and meta-analysis","volume":"147","author":"El-Andari","year":"2022","journal-title":"Cardiology"},{"key":"10.1016\/j.jhlto.2026.100677_bib29","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.jacc.2018.09.013","article-title":"Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial","volume":"72","author":"Zhang","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2026.100677_bib30","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI Guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100677_bib31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jcin.2008.10.001","article-title":"Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy","volume":"1","author":"Lee","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jhlto.2026.100677_bib32","first-page":"962","article-title":"Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature","volume":"77","author":"Dasari","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jhlto.2026.100677_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2022.10.056","article-title":"First- versus new-generation drug-eluting stents in patients with heart transplant with cardiac allograft vasculopathy","volume":"188","author":"Munafo","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhlto.2026.100677_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.carrev.2024.07.006","article-title":"Restenosis rates for drug-eluting stents used in treating small vessel cardiac allograft vasculopathy after orthotopic heart transplantation","volume":"73","author":"Elhage Hassan","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jhlto.2026.100677_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2025.100408","article-title":"The efficacy of biodegradable polymer everolimus-eluting stents in patients with cardiac allograft vasculopathy","volume":"10","author":"Tsuji","year":"2025","journal-title":"JHLT Open"},{"key":"10.1016\/j.jhlto.2026.100677_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacc.2006.01.081","article-title":"In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease","volume":"48","author":"Jonas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2026.100677_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017231","article-title":"Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials","volume":"8","author":"Cai","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhlto.2026.100677_bib38","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.transproceed.2017.06.010","article-title":"Drug-eluting balloons-a new tool in the treatment of cardiac allograft vasculopathy: a case series","volume":"49","author":"Skoric","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhlto.2026.100677_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2026.100607","article-title":"Drug-coated balloon treatment of in-stent restenosis in complex severe cardiac allograft vasculopathy","volume":"13","author":"Popoola","year":"2026","journal-title":"JHLT Open"},{"key":"10.1016\/j.jhlto.2026.100677_bib40","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2026.100677_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003265","article-title":"Impact of statin use after heart transplantation: a meta-analysis","volume":"9","author":"Vallakati","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2026.100677_bib42","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jchf.2024.04.026","article-title":"Randomized trial of cholesterol lowering with evolocumab for cardiac allograft vasculopathy in heart transplant recipients","volume":"12","author":"Broch","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jhlto.2026.100677_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.125.077603","article-title":"Cardiac allograft vasculopathy inhibition with alirocumab: the CAVIAR trial","volume":"153","author":"Fearon","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100677_bib44","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transplant"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:09:27Z","timestamp":1793786967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133426001989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S2950133426001989"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100677","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous coronary intervention in cardiac allograft vasculopathy: From lesion selection to longitudinal graft management","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100677"}}